Literature DB >> 7537739

Selective activation of the rat hepatic endosomal insulin receptor kinase. Role for the endosome in insulin signaling.

A P Bevan1, J W Burgess, P G Drake, A Shaver, J J Bergeron, B I Posner.   

Abstract

Insulin administration activates the insulin receptor kinase (IRK) in both plasma membrane (PM) and endosomes (ENs) raising the possibility of transmembrane signaling occurring in the endosomal compartment. Peroxovanadium compounds activate the IRK by inhibiting IR-associated phosphotyrosine phosphatase(s). Following the administration of the phosphotyrosine phosphatase inhibitor bisperoxo(1,10-phenanthroline)-oxovanadate (V) anion (bpV(phen)) activation of the hepatic IRK in ENs preceded that in PM by 5 min. When colchicine treatment preceded bpV(phen) administration IRK activation in ENs was unaffected but was totally abrogated in PM. Insulin receptor substrate-1 tyrosine phosphorylation followed the kinetics of IRK activation in ENs not PM and a hypoglycemic response similar to that achieved with a pharmacological dose of insulin ensued. These studies demonstrate that ENs constitute a site for IR-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537739     DOI: 10.1074/jbc.270.18.10784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor internalization.

Authors:  H Boudin; P Sarret; J Mazella; A Schonbrunn; A Beaudet
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.

Authors:  Rafal Robert Nazarewicz; Gloria Salazar; Nikolay Patrushev; Alejandra San Martin; Lula Hilenski; Shiqin Xiong; R Wayne Alexander
Journal:  J Biol Chem       Date:  2010-11-20       Impact factor: 5.157

Review 3.  Endosomes: a legitimate platform for the signaling train.

Authors:  Jane E Murphy; Benjamin E Padilla; Burcu Hasdemir; Graeme S Cottrell; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

4.  Regulation of catalase enzyme activity by cell signaling molecules.

Authors:  Sumio Yano; Noriko Yano
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 5.  Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases.

Authors:  B J Goldstein; F Ahmad; W Ding; P M Li; W R Zhang
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

Review 6.  Insulin receptor internalization and signalling.

Authors:  G M Di Guglielmo; P G Drake; P C Baass; F Authier; B I Posner; J J Bergeron
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  The last enzyme of the de novo purine synthesis pathway 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC) plays a central role in insulin signaling and the Golgi/endosomes protein network.

Authors:  Martial Boutchueng-Djidjou; Gabriel Collard-Simard; Suzanne Fortier; Sébastien S Hébert; Isabelle Kelly; Christian R Landry; Robert L Faure
Journal:  Mol Cell Proteomics       Date:  2015-02-16       Impact factor: 5.911

8.  Epidermal growth factor-induced vacuolar (H+)-atpase assembly: a role in signaling via mTORC1 activation.

Authors:  Yanqing Xu; Amanda Parmar; Emmanuelle Roux; Alejandro Balbis; Victor Dumas; Stephanie Chevalier; Barry I Posner
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

9.  Tyrosine phosphorylation of p97 regulates transitional endoplasmic reticulum assembly in vitro.

Authors:  C Lavoie; E Chevet; L Roy; N K Tonks; A Fazel; B I Posner; J Paiement; J J Bergeron
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 10.  Insulin Signalling: The Inside Story.

Authors:  Barry I Posner
Journal:  Can J Diabetes       Date:  2016-09-07       Impact factor: 4.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.